Clinical significance of serum EGFR gene mutation and serum tumor markers in predicting tyrosine kinase inhibitor efficacy in lung adenocarcinoma

作者：Lingxin Feng, Jing Wang, Zhuang Yu, S. Song, Wenxin Zhai, Shenghua Dong, Hong Yu, Y. Zhang · 发表于：Clinical & Translational Oncology · 年份：2019 · DOI：10.1007/s12094-018-02014-6 · 被引用次数：26 · 研究领域：Lung Cancer Treatments and Mutations、Lung Cancer Research Studies、Radiomics and Machine Learning in Medical Imaging